文献速递皮肤肿瘤

儿童及青少年皮肤黑色素瘤肿瘤核分裂率预后价值

The prognostic value of tumor mitotic rate in children and adolescents with cutaneous melanoma: A retrospective cohort study.
PubMed 文献 · J Am Acad Dermatol · 2019-11-02

该回顾性队列研究纳入156例年龄<20岁、临床局限期皮肤黑色素瘤患者,评估原发肿瘤核分裂率的预后价值。中位随访61个月,5年黑色素瘤特异性生存率和无复发生存率分别为91%和84%。核分裂率是比肿瘤厚度更强的预后预测因子,且是唯一与无复发生存独立相关的因素。

要点

  • 核分裂率≥1/mm2见于67%的儿童及青少年黑色素瘤患者,且与Breslow厚度增加相关。
  • 核分裂率是比肿瘤厚度更强的预后预测因子,且是唯一独立预测无复发生存的因子。
  • 5年黑色素瘤特异性生存率和无复发生存率分别为91%和84%。

核心结论

  • 核分裂率是儿童及青少年临床局限期黑色素瘤无复发生存的独立预测因子。

研究设计与样本

  • 回顾性队列研究,纳入156例年龄<20岁、临床局限期皮肤黑色素瘤患者,其中<12岁为儿童,12-19岁为青少年。
  • 收集临床病理及结局数据,计算无复发生存率和黑色素瘤特异性生存率,采用Cox比例风险模型进行单变量和多变量分析。
  • 中位随访时间为61个月。

主要发现

  • 104例(67%)患者核分裂率≥1/mm2,且核分裂率与Breslow厚度增加相关。
  • 61例接受前哨淋巴结活检的患者中23例(38%)前哨淋巴结阳性。
  • 5年黑色素瘤特异性生存率和无复发生存率分别为91%和84%。
  • 核分裂率是比肿瘤厚度更强的预后预测因子,且是唯一与无复发生存独立相关的因素。

临床怎么用

  • 在儿童及青少年黑色素瘤风险分层中应重视原发肿瘤核分裂率,其独立预测无复发生存。

局限性

  • 研究在单中心进行,样本量较小。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Mitotic rate is a strong predictor of outcome in adult patients with primary cutaneous melanoma, but for children and adolescent patients this is unknown. OBJECTIVE: We sought to assess the prognostic value of primary tumor mitotic rate in children and adolescents with primary melanoma. METHODS: This was a cohort study of 156 patients who were <20 years of age and who had clinically localized cutaneous melanoma. Patients <12 years of age were classified as children and those 12 to 19 years of age as adolescents. Clinicopathologic and outcome data were collected. Recurrence-free and melanoma-specific survival were calculated. Univariable and multivariable analyses were performed using Cox proportional hazard models. RESULTS: Thirteen of 156 patients (8%) were children. The mitotic rate was ≥1/mm2 in 104 patients (67%) and correlated with increasing Breslow thickness. A positive sentinel node was found in 23 of 61 patients (38%) in whom a sentinel lymph node biopsy specimen was obtained. The median follow-up was 61 months. Five-year melanoma-specific and recurrence-free survival rates were 91% and 84%, respectively. Mitotic rate was a stronger predictor of outcome than tumor thickness and was the only factor independently associated with recurrence-free survival. LIMITATIONS: This research was conducted at a single institution and the sample size was small. CONCLUSION: Mitotic rate is an independent predictor of recurrence-free survival in children and adolescents with clinically localized melanoma.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Ipenburg NA, Lo SN, Vilain RE, et al. The prognostic value of tumor mitotic rate in children and adolescents with cutaneous melanoma: A retrospective cohort study. J Am Acad Dermatol. 2019. PMID: 31682859. doi:10.1016/j.jaad.2019.10.065

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。